Showing 2101-2110 of 5615 results for "".
Disease-Modifying Advances in ATTR-CM Management
https://reachmd.com/programs/heart-matters/disease-modifying-attr-cm-management/49063/JAK Inhibitors in Psoriatic Arthritis: Reassessing Safety in the Real World
https://reachmd.com/programs/living-rheum/jak-inhibitors-psoriatic-arthritis-safety-real-world/56344/Early ALS Patients Show Slowed Decline with Pridopidine Treatment
https://reachmd.com/programs/clinicians-roundtable/early-als-patients-show-slowed-decline-with-pridopidine-treatment/54640/Biological and Environmental Factors in Facial Eczema
https://reachmd.com/topics/atopic-dermatitis/biological-and-environmental-factors-in-facial-eczema/54270/Comorbidities in Psoriasis
https://reachmd.com/topics/psoriasis/comorbidities-in-psoriasis/54453/Psoriasis is associated with numerous systemic comorbidities, many of which are linked through IL-17/IL-23-mediated inflammation. Comorbid conditions such as diabetes, IBD, metabolic syndrome, and PsA are not only more prevalent but often more severe in psoriasis patients, highlighting the importanReimagining the Aesthetic Surgery Experience
https://reachmd.com/topics/practice-development/reimagining-the-aesthetic-surgery-experience/49013/How Greenwich Street Surgical came to lifeManaging Genotype-Positive Patients in Hereditary ATTR-CM
https://reachmd.com/programs/on-the-frontlines-of-attr-cm/managing-genotype-positive-patients-in-hereditary-attr-cm/39316/Hereditary transthyretin amyloid cardiomyopathy (ATTRv-CM) can pose unique challenges for clinicians, particularly when it comes to treating genotype-positive individuals without overt symptoms. That's why a recent study explored the clinical characteristics, progression, and outcomes of family membThe Skin and the Pursuit of Beauty
https://reachmd.com/topics/skincare/the-skin-and-the-pursuit-of-beauty/36685/With Steven H. Dayan, MD, FACSMenin Inhibitors: Biologic and Clinical Rationale
https://reachmd.com/programs/cme/menin-inhibitors-biologic-and-clinical-rationale/36179/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.Launching Your Private Practice: Key Steps for Success
https://reachmd.com/ma-issues-index/2025-may-june/launching-your-private-practice-key-steps-for-success/36075/An engaging session with Dr. Michael Somenek